Conventional Treatment Options
Current treatment options for patients with heart failure, specifically mitral regurgitation, include medical management through the use of prescription medications or, in some cases, surgical treatments. Unfortunately, many patients are not eligible for open-heart or open-chest surgery because of their overall health and the risks of an open surgical procedure that requires general anesthesia.
Existing Treatment Options for FMR
Currently there are two surgical treatment options for functional mitral regurgitation: mitral annuloplasty and mitral valve replacement. When successful, these surgical alternatives deliver excellent chronic efficacy and improved long term outcomes. Unfortunately, these cardiac surgical procedures have associated morbidity and mortality, and consequently only a small percentage of CHF patients suffering from MR are referred for surgery. The current dominant treatment option for patients with CHF and associated MR is medical management, which fails to address the MR directly.
New Treatment Option
Recent reports have indicated that a non-surgical percutaneous therapy may be helpful for treating FMR in patients with heart failure.
The CARILLON™ Mitral Contour System™ was developed for the treatment of functional mitral regurgitation, a condition frequently associated with heart failure. This groundbreaking therapy consists of an implant and a delivery system that is designed to tighten the valve leaflets and improve mitral regurgitation.
Access / Introduction of Device
In this non-surgical procedure, a catheter is threaded into the heart via the jugular vein.
More Information
For more information, search "Heart Valve Disease" at the following sites: